"If the DSMB reports that the clinical trial is
Post# of 155321
(Total Views: 555)
Posted On: 10/20/2020 7:55:05 AM
"If the DSMB reports that the clinical trial is likely to meet its endpoint and that they should continue the trial, CytoDyn will likely immediately apply for Emergency Use Authorization from the FDA."
From Zerohedge^^^
So maybe the will or did apply for EAU?
I know that alone can slow enrollment so dboutful but couldn’t it also get us exposure, maybe it actually speeds up enrollment?
I don’t see how this can’t happen still. Makes sense to do it. Then again tho is just imo...
From Zerohedge^^^
So maybe the will or did apply for EAU?
I know that alone can slow enrollment so dboutful but couldn’t it also get us exposure, maybe it actually speeds up enrollment?
I don’t see how this can’t happen still. Makes sense to do it. Then again tho is just imo...
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Daniel Rizzo
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
SEC Submission: HL-1412396
DOJ Reference: 20250705-0001
Founder & CEO of FireGate Bioscience
Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
???? FireGate Bioscience: https://www.firegatebioscience.com
???? NotYourDrug.com: https://www.notyourdrug.com
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
SEC Submission: HL-1412396
DOJ Reference: 20250705-0001
Founder & CEO of FireGate Bioscience
Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
???? FireGate Bioscience: https://www.firegatebioscience.com
???? NotYourDrug.com: https://www.notyourdrug.com